TC-D101 / TCRCure - LARVOL DELTA

Preliminary Exploratory Clinical Study of TC-D101 in the Treatment of DLL3-Positive Relapsed/Refractory Primary Small-Cell Lung Cancer (ChiCTR) - P=N/A | N=8 | Not yet recruiting | Sponsor: Eastern Theater Command General Hospital of the Chinese People's Liberation Army (Jinling Hospital, Affiliated to Nanjing University Medical School);

New trial • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor • DLL3 • GRP-10

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: TCRCure Biopharma Ltd.

New P1 trial • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor